Report cover image

Global Finasteride Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 199 Pages
SKU # APRC20557610

Description

Summary

According to APO Research, the global Finasteride market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Finasteride market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Finasteride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Finasteride market include Teva Pharmaceuticals, Sandoz, Shandong Renhetang Pharmaceutical, Merck, Zhejiang CONBA Pharmaceutical, Henan Topfond, Guangdong Eashu Pharmacetical, RelonChem and Dr. Reddy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Finasteride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Finasteride, also provides the sales of main regions and countries. Of the upcoming market potential for Finasteride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Finasteride sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Finasteride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Finasteride sales, projected growth trends, production technology, application and end-user industry.

Finasteride Segment by Company

Teva Pharmaceuticals
Sandoz
Shandong Renhetang Pharmaceutical
Merck
Zhejiang CONBA Pharmaceutical
Henan Topfond
Guangdong Eashu Pharmacetical
RelonChem
Dr. Reddy
Cipla
Actavis
Accord Pharmaceuticals
Finasteride Segment by Type

1mg Tablet
5mg Tablet
Finasteride Segment by Application

Medical Uses
Application 2
Finasteride Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Finasteride status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Finasteride market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Finasteride significant trends, drivers, influence factors in global and regions.
6. To analyze Finasteride competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Finasteride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Finasteride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Finasteride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Finasteride market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Finasteride industry.
Chapter 3: Detailed analysis of Finasteride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Finasteride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Finasteride in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

199 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Finasteride Sales Value (2020-2031)
1.2.2 Global Finasteride Sales Volume (2020-2031)
1.2.3 Global Finasteride Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Finasteride Market Dynamics
2.1 Finasteride Industry Trends
2.2 Finasteride Industry Drivers
2.3 Finasteride Industry Opportunities and Challenges
2.4 Finasteride Industry Restraints
3 Finasteride Market by Company
3.1 Global Finasteride Company Revenue Ranking in 2024
3.2 Global Finasteride Revenue by Company (2020-2025)
3.3 Global Finasteride Sales Volume by Company (2020-2025)
3.4 Global Finasteride Average Price by Company (2020-2025)
3.5 Global Finasteride Company Ranking (2023-2025)
3.6 Global Finasteride Company Manufacturing Base and Headquarters
3.7 Global Finasteride Company Product Type and Application
3.8 Global Finasteride Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Finasteride Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Finasteride Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Finasteride Market by Type
4.1 Finasteride Type Introduction
4.1.1 1mg Tablet
4.1.2 5mg Tablet
4.2 Global Finasteride Sales Volume by Type
4.2.1 Global Finasteride Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Finasteride Sales Volume by Type (2020-2031)
4.2.3 Global Finasteride Sales Volume Share by Type (2020-2031)
4.3 Global Finasteride Sales Value by Type
4.3.1 Global Finasteride Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Finasteride Sales Value by Type (2020-2031)
4.3.3 Global Finasteride Sales Value Share by Type (2020-2031)
5 Finasteride Market by Application
5.1 Finasteride Application Introduction
5.1.1 Medical Uses
5.1.2 Application 2
5.2 Global Finasteride Sales Volume by Application
5.2.1 Global Finasteride Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Finasteride Sales Volume by Application (2020-2031)
5.2.3 Global Finasteride Sales Volume Share by Application (2020-2031)
5.3 Global Finasteride Sales Value by Application
5.3.1 Global Finasteride Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Finasteride Sales Value by Application (2020-2031)
5.3.3 Global Finasteride Sales Value Share by Application (2020-2031)
6 Finasteride Regional Sales and Value Analysis
6.1 Global Finasteride Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Finasteride Sales by Region (2020-2031)
6.2.1 Global Finasteride Sales by Region: 2020-2025
6.2.2 Global Finasteride Sales by Region (2026-2031)
6.3 Global Finasteride Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Finasteride Sales Value by Region (2020-2031)
6.4.1 Global Finasteride Sales Value by Region: 2020-2025
6.4.2 Global Finasteride Sales Value by Region (2026-2031)
6.5 Global Finasteride Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Finasteride Sales Value (2020-2031)
6.6.2 North America Finasteride Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Finasteride Sales Value (2020-2031)
6.7.2 Europe Finasteride Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Finasteride Sales Value (2020-2031)
6.8.2 Asia-Pacific Finasteride Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Finasteride Sales Value (2020-2031)
6.9.2 South America Finasteride Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Finasteride Sales Value (2020-2031)
6.10.2 Middle East & Africa Finasteride Sales Value Share by Country, 2024 VS 2031
7 Finasteride Country-level Sales and Value Analysis
7.1 Global Finasteride Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Finasteride Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Finasteride Sales by Country (2020-2031)
7.3.1 Global Finasteride Sales by Country (2020-2025)
7.3.2 Global Finasteride Sales by Country (2026-2031)
7.4 Global Finasteride Sales Value by Country (2020-2031)
7.4.1 Global Finasteride Sales Value by Country (2020-2025)
7.4.2 Global Finasteride Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Finasteride Sales Value Growth Rate (2020-2031)
7.5.2 USA Finasteride Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Finasteride Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Finasteride Sales Value Growth Rate (2020-2031)
7.6.2 Canada Finasteride Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Finasteride Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Finasteride Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Finasteride Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Finasteride Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Finasteride Sales Value Growth Rate (2020-2031)
7.8.2 Germany Finasteride Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Finasteride Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Finasteride Sales Value Growth Rate (2020-2031)
7.9.2 France Finasteride Sales Value Share by Type, 2024 VS 2031
7.9.3 France Finasteride Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Finasteride Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Finasteride Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Finasteride Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Finasteride Sales Value Growth Rate (2020-2031)
7.11.2 Italy Finasteride Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Finasteride Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Finasteride Sales Value Growth Rate (2020-2031)
7.12.2 Spain Finasteride Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Finasteride Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Finasteride Sales Value Growth Rate (2020-2031)
7.13.2 Russia Finasteride Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Finasteride Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Finasteride Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Finasteride Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Finasteride Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Finasteride Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Finasteride Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Finasteride Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Finasteride Sales Value Growth Rate (2020-2031)
7.16.2 China Finasteride Sales Value Share by Type, 2024 VS 2031
7.16.3 China Finasteride Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Finasteride Sales Value Growth Rate (2020-2031)
7.17.2 Japan Finasteride Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Finasteride Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Finasteride Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Finasteride Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Finasteride Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Finasteride Sales Value Growth Rate (2020-2031)
7.19.2 India Finasteride Sales Value Share by Type, 2024 VS 2031
7.19.3 India Finasteride Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Finasteride Sales Value Growth Rate (2020-2031)
7.20.2 Australia Finasteride Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Finasteride Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Finasteride Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Finasteride Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Finasteride Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Finasteride Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Finasteride Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Finasteride Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Finasteride Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Finasteride Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Finasteride Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Finasteride Sales Value Growth Rate (2020-2031)
7.24.2 Chile Finasteride Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Finasteride Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Finasteride Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Finasteride Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Finasteride Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Finasteride Sales Value Growth Rate (2020-2031)
7.26.2 Peru Finasteride Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Finasteride Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Finasteride Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Finasteride Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Finasteride Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Finasteride Sales Value Growth Rate (2020-2031)
7.28.2 Israel Finasteride Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Finasteride Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Finasteride Sales Value Growth Rate (2020-2031)
7.29.2 UAE Finasteride Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Finasteride Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Finasteride Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Finasteride Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Finasteride Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Finasteride Sales Value Growth Rate (2020-2031)
7.31.2 Iran Finasteride Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Finasteride Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Finasteride Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Finasteride Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Finasteride Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Teva Pharmaceuticals
8.1.1 Teva Pharmaceuticals Comapny Information
8.1.2 Teva Pharmaceuticals Business Overview
8.1.3 Teva Pharmaceuticals Finasteride Sales, Value and Gross Margin (2020-2025)
8.1.4 Teva Pharmaceuticals Finasteride Product Portfolio
8.1.5 Teva Pharmaceuticals Recent Developments
8.2 Sandoz
8.2.1 Sandoz Comapny Information
8.2.2 Sandoz Business Overview
8.2.3 Sandoz Finasteride Sales, Value and Gross Margin (2020-2025)
8.2.4 Sandoz Finasteride Product Portfolio
8.2.5 Sandoz Recent Developments
8.3 Shandong Renhetang Pharmaceutical
8.3.1 Shandong Renhetang Pharmaceutical Comapny Information
8.3.2 Shandong Renhetang Pharmaceutical Business Overview
8.3.3 Shandong Renhetang Pharmaceutical Finasteride Sales, Value and Gross Margin (2020-2025)
8.3.4 Shandong Renhetang Pharmaceutical Finasteride Product Portfolio
8.3.5 Shandong Renhetang Pharmaceutical Recent Developments
8.4 Merck
8.4.1 Merck Comapny Information
8.4.2 Merck Business Overview
8.4.3 Merck Finasteride Sales, Value and Gross Margin (2020-2025)
8.4.4 Merck Finasteride Product Portfolio
8.4.5 Merck Recent Developments
8.5 Zhejiang CONBA Pharmaceutical
8.5.1 Zhejiang CONBA Pharmaceutical Comapny Information
8.5.2 Zhejiang CONBA Pharmaceutical Business Overview
8.5.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Value and Gross Margin (2020-2025)
8.5.4 Zhejiang CONBA Pharmaceutical Finasteride Product Portfolio
8.5.5 Zhejiang CONBA Pharmaceutical Recent Developments
8.6 Henan Topfond
8.6.1 Henan Topfond Comapny Information
8.6.2 Henan Topfond Business Overview
8.6.3 Henan Topfond Finasteride Sales, Value and Gross Margin (2020-2025)
8.6.4 Henan Topfond Finasteride Product Portfolio
8.6.5 Henan Topfond Recent Developments
8.7 Guangdong Eashu Pharmacetical
8.7.1 Guangdong Eashu Pharmacetical Comapny Information
8.7.2 Guangdong Eashu Pharmacetical Business Overview
8.7.3 Guangdong Eashu Pharmacetical Finasteride Sales, Value and Gross Margin (2020-2025)
8.7.4 Guangdong Eashu Pharmacetical Finasteride Product Portfolio
8.7.5 Guangdong Eashu Pharmacetical Recent Developments
8.8 RelonChem
8.8.1 RelonChem Comapny Information
8.8.2 RelonChem Business Overview
8.8.3 RelonChem Finasteride Sales, Value and Gross Margin (2020-2025)
8.8.4 RelonChem Finasteride Product Portfolio
8.8.5 RelonChem Recent Developments
8.9 Dr. Reddy
8.9.1 Dr. Reddy Comapny Information
8.9.2 Dr. Reddy Business Overview
8.9.3 Dr. Reddy Finasteride Sales, Value and Gross Margin (2020-2025)
8.9.4 Dr. Reddy Finasteride Product Portfolio
8.9.5 Dr. Reddy Recent Developments
8.10 Cipla
8.10.1 Cipla Comapny Information
8.10.2 Cipla Business Overview
8.10.3 Cipla Finasteride Sales, Value and Gross Margin (2020-2025)
8.10.4 Cipla Finasteride Product Portfolio
8.10.5 Cipla Recent Developments
8.11 Actavis
8.11.1 Actavis Comapny Information
8.11.2 Actavis Business Overview
8.11.3 Actavis Finasteride Sales, Value and Gross Margin (2020-2025)
8.11.4 Actavis Finasteride Product Portfolio
8.11.5 Actavis Recent Developments
8.12 Accord Pharmaceuticals
8.12.1 Accord Pharmaceuticals Comapny Information
8.12.2 Accord Pharmaceuticals Business Overview
8.12.3 Accord Pharmaceuticals Finasteride Sales, Value and Gross Margin (2020-2025)
8.12.4 Accord Pharmaceuticals Finasteride Product Portfolio
8.12.5 Accord Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Finasteride Value Chain Analysis
9.1.1 Finasteride Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Finasteride Sales Mode & Process
9.2 Finasteride Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Finasteride Distributors
9.2.3 Finasteride Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.